Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?
Ann Allergy Asthma Immunol
.
2022 Dec;129(6):667-668.
doi: 10.1016/j.anai.2022.09.001.
Author
Matthew Greenhawt
1
Affiliation
1
Section of Allergy and Immunology, Food Challenge and Research Unit, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: Matthew.Greenhawt@childrenscolorado.org.
PMID:
36464396
PMCID:
PMC9712058
DOI:
10.1016/j.anai.2022.09.001
No abstract available
Publication types
Editorial
Research Support, U.S. Gov't, P.H.S.
MeSH terms
COVID-19 / prevention & control
COVID-19 Vaccines* / administration & dosage
Humans
Vaccine Excipients*
Substances
COVID-19 Vaccines
Vaccine Excipients
Grants and funding
K08 HS024599/HS/AHRQ HHS/United States